SCHEMBL13873870

CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2OC[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](OCCOCCOCCOCCN)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H](C)[C@H]2OC)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O

nearest known ligand 0.57

Predicted protein targets (top 14)

	gene	UniProt	supporting neighbours	confidence
▸	SERPINC1	P01008	3/20	0.57

▸	CXCL10	P02778	1/20	0.46

▸	CXCL8	P10145	1/20	0.46

▸	CCL2	P13500	1/20	0.46

▸	CCL5	P13501	1/20	0.46

▸	CXCL12	P48061	1/20	0.46

▸	F10	P00742	6/20	0.41

▸	F2	P00734	2/20	0.39

▸	FGF1	P05230	4/20	0.39

▸	HPSE	Q9Y251	2/20	0.35

▸	FGF2	P09038	1/20	0.34

▸	BDNF	P23560	2/20	0.34

▸	PTN	P21246	1/20	0.34

▸	MDK	P21741	1/20	0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL12458594	0.95	SERPINC1 (0.59)	SERPINC1CXCL10CXCL8CCL2CCL5
SCHEMBL12799309	0.91	SERPINC1 (0.68)	SERPINC1CXCL10CXCL8CCL2CCL5
SCHEMBL14959633	0.84	SERPINC1 (0.57)	SERPINC1CXCL10CXCL8CCL2CCL5
SCHEMBL15896273	0.84	SERPINC1 (0.69)	SERPINC1CXCL10CXCL8CCL2CCL5
Idraparinux SCHEMBL427808	0.79	SERPINC1 (0.85)	SERPINC1F10F2FGF1HPSE
Idraparinux SCHEMBL29382311	0.79	SERPINC1 (0.85)	SERPINC1F10F2FGF1HPSE
SCHEMBL29407493	0.79	SERPINC1 (0.85)	SERPINC1F10F2FGF1HPSE
SCHEMBL14227804	0.78	SERPINC1 (0.40)	SERPINC1CXCL10CXCL8CCL2CCL5
SCHEMBL15896277	0.77	SERPINC1 (0.59)	SERPINC1CXCL10CXCL8CCL2CCL5
SCHEMBL12729453	0.76	SERPINC1 (0.74)	SERPINC1CXCL10CXCL8CCL2CCL5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20090111769-A1	Antithrombotic Compound	MSD OSS B.V. (NL)	2009-04-30	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20090111769-A1	Antithrombotic Compound	TFPI, FGB, SERPINC1	SERPINC1 3/4885CXCL10 2562/4885CXCL8 1808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.